Cooper Companies Inc (NYSE:COO) – Analysts at Northcoast Research cut their Q3 2019 EPS estimates for shares of Cooper Companies in a research report issued on Tuesday, May 28th, Zacks Investment Research reports. Northcoast Research analyst D. Keiser now forecasts that the medical device company will post earnings per share of $3.20 for the quarter, down from their previous forecast of $3.21. Northcoast Research has a “Buy” rating and a $340.00 price target on the stock. Northcoast Research also issued estimates for Cooper Companies’ Q2 2020 earnings at $3.23 EPS.
Other equities research analysts have also issued research reports about the stock. Zacks Investment Research raised shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 price objective on the stock in a research note on Friday, June 7th. Wells Fargo & Co raised their price target on shares of Cooper Companies from $325.00 to $356.00 and gave the stock an “outperform” rating in a research note on Monday. Raymond James increased their target price on shares of Cooper Companies from $300.00 to $325.00 and gave the stock an “outperform” rating in a report on Wednesday, March 6th. BMO Capital Markets increased their target price on shares of Cooper Companies from $306.00 to $320.00 and gave the stock an “outperform” rating in a report on Wednesday, March 6th. Finally, Stephens increased their target price on shares of Cooper Companies from $305.00 to $320.00 and gave the stock an “overweight” rating in a report on Wednesday, March 6th. One analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $315.36.
NYSE:COO traded down $1.46 on Thursday, hitting $323.10. The stock had a trading volume of 261,026 shares, compared to its average volume of 347,377. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.68 and a current ratio of 1.21. The firm has a market cap of $16.24 billion, a price-to-earnings ratio of 28.10, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78. Cooper Companies has a 1 year low of $228.65 and a 1 year high of $329.88.
Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, May 30th. The medical device company reported $2.94 EPS for the quarter, beating the consensus estimate of $2.76 by $0.18. Cooper Companies had a net margin of 16.46% and a return on equity of 17.25%. The business had revenue of $654.30 million during the quarter, compared to the consensus estimate of $655.00 million. During the same period in the previous year, the business earned $2.86 earnings per share. The company’s revenue was up 3.6% on a year-over-year basis.
In other Cooper Companies news, Director Robert S. Weiss sold 52,156 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $323.74, for a total transaction of $16,884,983.44. Following the completion of the transaction, the director now directly owns 154,975 shares of the company’s stock, valued at approximately $50,171,606.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert S. Weiss sold 70,902 shares of the firm’s stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $291.81, for a total transaction of $20,689,912.62. Following the transaction, the director now directly owns 117,185 shares of the company’s stock, valued at $34,195,754.85. The disclosure for this sale can be found here. Insiders sold a total of 150,856 shares of company stock worth $46,131,542 over the last 90 days. Company insiders own 1.70% of the company’s stock.
Institutional investors and hedge funds have recently bought and sold shares of the business. Essex Savings Bank purchased a new position in shares of Cooper Companies during the 4th quarter valued at approximately $25,000. Certified Advisory Corp purchased a new position in shares of Cooper Companies during the 4th quarter valued at approximately $25,000. Executive Wealth Management LLC purchased a new position in shares of Cooper Companies during the 4th quarter valued at approximately $34,000. Financial Gravity Companies Inc. purchased a new position in shares of Cooper Companies during the 4th quarter valued at approximately $46,000. Finally, Quadrant Capital Group LLC increased its holdings in shares of Cooper Companies by 827.8% during the 1st quarter. Quadrant Capital Group LLC now owns 167 shares of the medical device company’s stock valued at $47,000 after purchasing an additional 149 shares in the last quarter. 95.98% of the stock is owned by institutional investors.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.